A new minimally ablative stem cell transplantation procedure in high-risk patients not eligible for nonmyeloablative allogeneic bone marrow transplantation.
Shapira, M Y
A new minimally ablative stem cell transplantation procedure in high-risk patients not eligible for nonmyeloablative allogeneic bone marrow transplantation. [electronic resource] - Bone marrow transplantation Sep 2003 - 557-61 p. digital
Publication Type: Clinical Trial; Journal Article
0268-3369
10.1038/sj.bmt.1704190 doi
Adult
Busulfan--administration & dosage
Cyclosporine--therapeutic use
Female
Graft Survival
Graft vs Host Disease--drug therapy
Hematopoietic Stem Cell Mobilization
Hematopoietic Stem Cell Transplantation--methods
Humans
Immunosuppressive Agents--therapeutic use
Male
Middle Aged
Neoplasms--mortality
Patient Selection
Pilot Projects
Transplantation Conditioning--methods
Transplantation, Homologous
Treatment Outcome
Vidarabine--administration & dosage
A new minimally ablative stem cell transplantation procedure in high-risk patients not eligible for nonmyeloablative allogeneic bone marrow transplantation. [electronic resource] - Bone marrow transplantation Sep 2003 - 557-61 p. digital
Publication Type: Clinical Trial; Journal Article
0268-3369
10.1038/sj.bmt.1704190 doi
Adult
Busulfan--administration & dosage
Cyclosporine--therapeutic use
Female
Graft Survival
Graft vs Host Disease--drug therapy
Hematopoietic Stem Cell Mobilization
Hematopoietic Stem Cell Transplantation--methods
Humans
Immunosuppressive Agents--therapeutic use
Male
Middle Aged
Neoplasms--mortality
Patient Selection
Pilot Projects
Transplantation Conditioning--methods
Transplantation, Homologous
Treatment Outcome
Vidarabine--administration & dosage